We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb: FDA Exploring User Fees for Generics
Gottlieb: FDA Exploring User Fees for Generics
February 24, 2006
A top FDA official has suggested generic drug companies pay user fees to help expedite the generic drug-review process — a proposal that comes as the agency’s generics division faces a backlog of applications and virtually flat funding in fiscal 2007.